Introducing Amazon Bio Discovery
Industries Blog
This article introduces Amazon Bio Discovery, a new agentic application that democratizes lab-in-the-loop drug discovery for research organizations.
- Integrates 40+ AI biology models with AI-guided selection for computational workflows
- No-code environment for computational biologists to build and publish reusable workflows
- AI agents guide bench scientists through experiment design, model selection, and candidate evaluation
- Seamless integration with CRO partners (Ginkgo Bioworks, Twist Bioscience, A-Alpha Bio) for wet-lab validation
- Automated feedback loop: wet-lab results flow back to refine models and improve predictions
- Enterprise-grade security with data isolation for proprietary research and custom models
- Demonstrated success: designed 300,000 antibody candidates in weeks versus traditional year-long process
Amazon Bio Discovery bridges the collaboration gap between computational and bench scientists, making advanced drug discovery accessible and scalable across research organizations.
The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.
Related articles
May 7
2026
2026
Closing the Loop with Amazon Bio Discovery’s Integrated Lab Partners
Apr 9
2026
2026
AWS Marketplace announces the Discovery API for programmatic access to catalog data
Apr 21
2026
2026
Breaking Down Barriers: How AWS Democratizes Genomic Data for the World
Jun 1
2026
2026
Transforming rare cancer research with Amazon Quick: Integrating biomedical databases for breakthrough discoveries
The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.